HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1

AIDS Research and Human Retroviruses

Volumn 15, Issue 9, 1999, Pages 821-827

  Moriuchi, Masako ^a   Moriuchi, Hiroyuki ^a,b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONOMYCIN; MITOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; TAX PROTEIN; VIRUS PROTEIN;

ARTICLE; BINDING SITE; DNA BINDING; GENE EXPRESSION REGULATION; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T CELL LEUKEMIA; VIRUS INFECTION;

EID: 0033065001     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310728     Document Type: Article

References (43)

1. Høllsberg P and Hafler DA: Pathogenesis of disease induced by human lymphotropic virus type I infection. N Engl J Med 1993; 328:1173-1182.
2. Uchiyama T: Human T cell leukemia virus type 1 (HTLV-I) and human diseases. Annu Rev Immunol 1997;15:15-37.
3. Franchini G: Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type I infection. Blood 1995;86:3619-3639.
4. Yoshida M: HTLV-I oncoprotein Tax deregulates transcription of cellular genes through multiple mechanisms. J Cancer Res Clin Oncol 1995;121:521-528.
5. Bantignies F, Rousset R, Desbois C, and Jalinot P: Genetic characterization of the human T-cell leukemia virus type 1 promoter: Binding of Tax to Tax-responsive element 1 is mediated by the cyclic AMP-responsive members of the CREB/ATF family of transcription factors. Mol Cell Biol 1996;16:2174-2182.
6. Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, Nyborg JK, and Schepartz A: Mechanism of DNA-binding enhancement by the human T-cell leukemia virus transactivator Tax. Nature (London) 1995;376:606-608.
7. Wagner S and Greene MR: HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 1993;262:395-399.
8. Zhao LJ and Giam CZ: Interaction of the human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc Natl Acad Sci USA 1991;88: 11445-11449.
9. Jeang KT, Widen SG, Semmes OJ, and Wilson SH: HTLV-I trans-activator protein, Tax, is a trans-repressor of the human β-polymerase gene. Science 1990;247:1082-1084.
10. Uittenbogaard MN, Armstrong AP, Chiaramello A, and Nyborg JK: Human T-cell leukemia virus type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J Biol Chem 1994;269:22466-22469.
11. Uittenbogaard MN, Giebler HA, Reisman D, and Nyborg JK: Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J Biol Chem 1995;270:28503-28506.
12. Feng Y, Broder C, Kennedy PE, and Berger EA: HIV-1 entry co-factor: Functional cDN A cloning of a seven-transmembrane G-protein-coupled receptor. Science 1996;272:872-877.
13. Virbasius CA, Virbasius JV, and Scarpulla RC: NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators. Genes Dev 1993;7:2431-2445.
14. Moriuchi H, Moriuchi M, and Fauci AS: Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: Implications for in vivo coinfection with HTLV-I and HIV-1. J Exp Med 1998;187:1689-1697.
15. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetsher P, Baggiolini M, Virelizier JL, and Arenzana-Seisdedos F: HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186: 139-146.
16. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185: 1681-1689.
17. Moriuchi M, Moriuchi H, Turner W, and Fauci AS: Cloning and analysis of the promoter region for CXCR4, a co-receptor for HIV-1 entry. J Immunol 1997;159:4322-4329.
18. Moriuchi H, Moriuchi M, and Fauci AS: Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 1997;158:3483-3491.
19. Himes SR, Katsikeros R, and Shannon MF: Costimulation of cytokine gene expression in T cells by the human T leukemia/ lymphotropic virus type I trans activator Tax. J Virol 1993;70: 4001-4008.
20. tax protein in the human T-cell line, Jurkat. J Virol 1989;68:3220-3226.
21. Wegner SA, Ehrenberg PK, Chang G, Dayhoff DE, Sleeker AL, and Michael NL: Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1. J Biol Chem 1998;273:4754-4760.
22. Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL, Parmentier M, and Arenzana-Seisdedos F: Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett 1998;426:271-278.
23. Tie F, Adya N, Greene WC, and Giam CZ: Interaction of the human T-lymphotropic virus type 1 Tax dimer with CREB and the viral 21-base-pair repeat. J Virol 1996;70:8368-8374.
24. Moriuchi H, Moriuchi M, and Cohen JI: Proteins and cis acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein. J Virol 1995;69:4693-4701.
25. Virbasius CA, Virbasius JV, and Scarpula RC: NRF-1: A trans-activator of nuclear-encoded respiratory genes in animal cells. Genes Dev 1990;4:1023-1034.
26. Meier JL, Luo X, Sawadogo M, and Straus SE: The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol Cell Biol 1994;14:6896-6906.
27. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, and Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (London) 1996;382:829-833.
28. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, and Moser B: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature (London) 1996;382: 833-835.
29. Gugneja S and Scarpula R: Serine phosphorylation within a concise amino-terminal domain in nuclear respiratory factor 1 enhances DNA binding. J Biol Chem 1997;272:18732-18739.
30. Bartholomew C, Blattner WA, and Cleghorn F: Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet 1987;2:1469.
31. Cleghorn FR and Blattner WA: Does human T-lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome? Ann Intern Med 1992;152:1372-1373.
32. Fantry L, Dodging E, Auwaerter PG, and Lederman HM: Immunodeficiency and elevated CD4 lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. Clin Infect Dis 1995;21:1446-1448.
33. Gotuzzo E, Escamilla J, Phillips IA, Sanchez J, Wignall FS, and Antigoni J: The impact of human T-lymphotropic virus type I/II infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome. Ann Intern Med 1992;152: 1429-1432.
34. Page JB, Lai SH, Chitwood DD, Klimas NG, Smith PC, and Fletcher MA: HTLV-I/II positivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet 1990;335: 1439-1441.
35. Pagiuca A and Mufti GJ: Co-infection with HTLV-I/II and HIV-1. Lancet 1990;336:383.
36. Schechter M, Harrison LH, Halsey NA, Trade G, Santino M, Harrison LH, and Quinn TC: Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA 1994;271:353-357.
37. Signoret N, Oldridge J, Pelchen-Matthews A, Klasse PJ, Tran T, Brass LF, Rosenkilde MM, Schwartz TW, Holmes W, Dallas W, Luther MA, Wells TNC, Hoxie JA, and Marsh M: Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 1997;139:651-664.
38. Connor RI, Sheridan KE, Ceradini C, Choe S, and Landau NR: Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997;185:621-628.
39. Schuitemaker H, Koot M, Koostra NA, Derksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, and Tersmette M: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992;66:1354-1360.
40. Siekevitz M, Josephs SF, Dukovich M, Peffer N, Wong-Staal F, and Greene WC: Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 1987;238: 1575-1578.
41. 1 protein. New Biol 1990; 2:1034-1043.
42. 1 protein stimulates proliferation of human peripheral blood lymphocytes. New Biol 1991;3:678-686.
43. Dhib-Jalbut S, Hoffman PM, Yamabe T, Sun D, Xia J, Eisenberg H, Berger G, and Ruscetti FW: Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann Neurol 1994;36:787-790.